Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Drugmakers Come Together Hoping to Formalize MRD as Surrogate Endpoint in AML Trials,

MPAACT, which stands for “Measurable residual disease Partnership and Alliance in Acute myeloid leukemia Clinical Treatment,” was established in 2018 …, MPAACT, which stands for “Measurable residual disease Partnership and Alliance in Acute myeloid leukemia Clinical Treatment,” was established in 2018 …, Read More

Scroll to Top